Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| (-)-trans-anti-N2-BPDE-dG-d8 | [7S-(7α,8β,9β,10α)]-2’-Deoxy-N-(7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo[a]pyren-10-yl)guanosine-d8; Benzo[a]pyrene, guanosine deriv.-d8; (-)-trans-anti-7,8,9-Trihydroxy-10-(2’-deoxyguanosin-2-yl)benzo[a]pyrene-d8 | [7S-(7alpha,8beta,9beta,10alpha)]-2-Deoxy-N-(7,8,9 | C30H19D8N5O7 | 577.61 | [7S-(7α,8β,9β,10α)]-2’-Deoxy-N-(7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo[a]pyren-10-yl)guanosine-d8; Benzo[a]pyrene, guanosine deriv.-d8; (-)-t... |
| Levetiracetam-d6 | (alphaS)-alpha-(Ethyl-1,1,2,2,2-d5)-2-oxo-1-pyrrolidineacetamide-alpha-d (-)-Levetiracetam-d6 Keppra-d6 Levesam 500-d6 UCB-L 059-d6 | 1133229-29-4 | C8H8D6N2O2 | 176.25 | (alphaS)-alpha-(Ethyl-1,1,2,2,2-d5)-2-oxo-1-pyrrolidineacetamide-alpha-d (-)-Levetiracetam-d6 Keppra-d6 Levesam 500-d6 UCB-L 059-d6 |
| (+/-)-trans-anti-N2-BPDE-dG-15N5 | [7S-(7alpha,8beta,9beta,10alpha)]-2-Deoxy-N-(7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo[a]pyren-10-yl)guanosine-15N5; Benzo[a]pyrene, guanosine deriv.-15N5; (+/-)-trans-anti-7,8,9-Trihydroxy-10-(2-deoxyguanosin-2-yl)benzo[a]pyrene-15N5 | C30H29 12N5O7 | 576.55 | [7S-(7alpha,8beta,9beta,10alpha)]-2-Deoxy-N-(7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo[a]pyren-10-yl)guanosine-15N5; Benzo[a]pyrene, guanosine deriv.-... | |
| Ethyl 3-(Trifluoromethyl)pyrazole-4-carboxylate | 3-(Trifluoromethyl)pyrazole-4-carboxylic Acid Ethyl Ester; 3-Trifluoromethyl-1H-pyrazole-4-carboxylic Acid Ethyl Ester; Ethyl 3-Trifluoromethyl-1H-pyrazole-4-carboxylate; Ethyl 3-Trifluoromethylpyrazole-4-carboxylate | 155377-19-8 | C7H7F3N2O2 | 208.14 | 3-(Trifluoromethyl)pyrazole-4-carboxylic Acid Ethyl Ester; 3-Trifluoromethyl-1H-pyrazole-4-carboxylic Acid Ethyl Ester; Ethyl 3-Trifluoromethyl-1H-pyr... |
| Levetiracetam-d3 | (alphaS)-alpha-(Ethyl-d3)-2-oxo-1-pyrrolidineacetamide (-)-Levetiracetam-d3 Keppra-d3 Levesam 500-d3 UCB-L 059-d3 | 1217851-16-5 | C8H11D3N2O2 | 173.23 | (alphaS)-alpha-(Ethyl-d3)-2-oxo-1-pyrrolidineacetamide (-)-Levetiracetam-d3 Keppra-d3 Levesam 500-d3 UCB-L 059-d3 |
| S-Ethyl Trifluorothioacetate | 2,2,2-Trifluoroethanethioic Acid S-Ethyl Ester; Trifluorothioacetic Acid S-Ethyl Ester; Trifluoroethanethioic Acid S-Ethyl Ester; NSC 88936; S-Ethyl Thiotrifluoroacetate | 383-64-2 | C4H5F3OS | 158.14 | 2,2,2-Trifluoroethanethioic Acid S-Ethyl Ester; Trifluorothioacetic Acid S-Ethyl Ester; Trifluoroethanethioic Acid S-Ethyl Ester; NSC 88936; S-Ethyl T... |
| (-)-cis-anti-N2-BPDE-dG | [7S-(7alpha,8beta,9beta,10beta)]-2-Deoxy-N-(7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo[a]pyren-10-yl)guanosine; Benzo[a]pyrene Guanosine deriv.; (-)-cis-anti-7,8,9-Trihydroxy-10-(2-deoxyguanosin-2-yl)benzo[a]pyrene | 66113-73-3 | C03H27N5O7 | 569.56 | [7S-(7alpha,8beta,9beta,10beta)]-2-Deoxy-N-(7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo[a]pyren-10-yl)guanosine; Benzo[a]pyrene Guanosine deriv.; (-)-ci... |
| Ethyl Trifluorocrotonate-13C3 | C2 13C4H7F3O2 | 172.08 | |||
| 1-Ethyl-2,3,3-trimethylindolenium-5-sulfonate | 1-Ethyl-2,3,3-trimethyl-5-sulfo-3H-indolium Inner Salt; | 146368-07-2 | C13H17NO3S | 267.34 | 1-Ethyl-2,3,3-trimethyl-5-sulfo-3H-indolium Inner Salt;
|
| Levetiracetam-d6 | (alphaS)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide-d6 (-)-Levetiracetam-d6 Keppra-d6 Levesam 500-d6 UCB-L 059-d6 | 1133229-30-7 | C8H8D6N2O2 | 176.25 | (alphaS)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide-d6 (-)-Levetiracetam-d6 Keppra-d6 Levesam 500-d6 UCB-L 059-d6 |
Page 1379 of 10017